These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38788719)
41. Triggering Receptor Expressed on Myeloid Cells 2 Deficiency Alters Acute Macrophage Distribution and Improves Recovery after Traumatic Brain Injury. Saber M; Kokiko-Cochran O; Puntambekar SS; Lathia JD; Lamb BT J Neurotrauma; 2017 Jan; 34(2):423-435. PubMed ID: 26976047 [TBL] [Abstract][Full Text] [Related]
42. Microglial TREM2 in amyotrophic lateral sclerosis. Xie M; Zhao S; Bosco DB; Nguyen A; Wu LJ Dev Neurobiol; 2022 Jan; 82(1):125-137. PubMed ID: 34874625 [TBL] [Abstract][Full Text] [Related]
43. TREM2 promotes natural killer cell development in CD3 Lee HY; Lee EH; Yi J; Ji KY; Kim SM; Choi HR; Yee SM; Kang HS; Kim EM BMC Immunol; 2021 May; 22(1):30. PubMed ID: 33980160 [TBL] [Abstract][Full Text] [Related]
44. Vps35-dependent recycling of Trem2 regulates microglial function. Yin J; Liu X; He Q; Zhou L; Yuan Z; Zhao S Traffic; 2016 Dec; 17(12):1286-1296. PubMed ID: 27717139 [TBL] [Abstract][Full Text] [Related]
45. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430 [TBL] [Abstract][Full Text] [Related]
46. Geniposide Enhances Macrophage Autophagy through Downregulation of TREM2 in Atherosclerosis. Xu YL; Liu XY; Cheng SB; He PK; Hong MK; Chen YY; Zhou FH; Jia YH Am J Chin Med; 2020; 48(8):1821-1840. PubMed ID: 33308094 [TBL] [Abstract][Full Text] [Related]
47. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease. McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708 [TBL] [Abstract][Full Text] [Related]
48. TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma. Raphael I; Kumar R; McCarl LH; Shoger K; Wang L; Sandlesh P; Sneiderman CT; Allen J; Zhai S; Campagna ML; Foster A; Bruno TC; Agnihotri S; Hu B; Castro BA; Lieberman FS; Broniscer A; Diaz AA; Amankulor NM; Rajasundaram D; Pollack IF; Kohanbash G Front Immunol; 2021; 12():637146. PubMed ID: 34025646 [TBL] [Abstract][Full Text] [Related]
49. Myeloid Cells in Glioblastoma Microenvironment. De Leo A; Ugolini A; Veglia F Cells; 2020 Dec; 10(1):. PubMed ID: 33374253 [TBL] [Abstract][Full Text] [Related]
50. Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer. Wang Q; Wu Y; Jiang G; Huang X J Exp Clin Cancer Res; 2024 Aug; 43(1):224. PubMed ID: 39135069 [TBL] [Abstract][Full Text] [Related]
51. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103 [TBL] [Abstract][Full Text] [Related]
52. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. Sieber MW; Jaenisch N; Brehm M; Guenther M; Linnartz-Gerlach B; Neumann H; Witte OW; Frahm C PLoS One; 2013; 8(1):e52982. PubMed ID: 23301011 [TBL] [Abstract][Full Text] [Related]
53. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth. Achyut BR; Angara K; Jain M; Borin TF; Rashid MH; Iskander ASM; Ara R; Kolhe R; Howard S; Venugopal N; Rodriguez PC; Bradford JW; Arbab AS Sci Rep; 2017 Oct; 7(1):13754. PubMed ID: 29062041 [TBL] [Abstract][Full Text] [Related]
54. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma. Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T Front Immunol; 2021; 12():637053. PubMed ID: 34108959 [TBL] [Abstract][Full Text] [Related]
55. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745 [TBL] [Abstract][Full Text] [Related]
57. TREM2: A new player in the tumor microenvironment. Molgora M; Liu YA; Colonna M; Cella M Semin Immunol; 2023 May; 67():101739. PubMed ID: 36989543 [TBL] [Abstract][Full Text] [Related]
58. Triggering Receptor Expressed on Myeloid Cells 2 Alleviated Sevoflurane-Induced Developmental Neurotoxicity via Microglial Pruning of Dendritic Spines in the CA1 Region of the Hippocampus. Deng L; Song SY; Zhao WM; Meng XW; Liu H; Zheng Q; Peng K; Ji FH Neurosci Bull; 2024 Sep; 40(9):1215-1229. PubMed ID: 39078595 [TBL] [Abstract][Full Text] [Related]
59. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression. Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529 [TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). Atagi Y; Liu CC; Painter MM; Chen XF; Verbeeck C; Zheng H; Li X; Rademakers R; Kang SS; Xu H; Younkin S; Das P; Fryer JD; Bu G J Biol Chem; 2015 Oct; 290(43):26043-50. PubMed ID: 26374899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]